Nexalin Technology (NXL) Projected to Post Quarterly Earnings on Wednesday

Nexalin Technology (NASDAQ:NXL) is anticipated to issue its results before the market opens on Wednesday, February 25th. Analysts expect the company to announce earnings of ($0.12) per share and revenue of $0.08 million for the quarter.

Nexalin Technology Trading Down 1.6%

Shares of NASDAQ:NXL opened at $0.49 on Tuesday. The company has a market capitalization of $9.14 million, a PE ratio of -0.74 and a beta of 3.95. Nexalin Technology has a twelve month low of $0.37 and a twelve month high of $3.03. The firm has a 50 day simple moving average of $0.62 and a 200-day simple moving average of $0.91.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. PEAK6 LLC acquired a new position in Nexalin Technology in the fourth quarter valued at $266,000. Geode Capital Management LLC grew its holdings in shares of Nexalin Technology by 23.4% during the fourth quarter. Geode Capital Management LLC now owns 150,274 shares of the company’s stock worth $84,000 after buying an additional 28,454 shares during the last quarter. Renaissance Technologies LLC increased its position in Nexalin Technology by 119.2% in the 4th quarter. Renaissance Technologies LLC now owns 122,100 shares of the company’s stock valued at $68,000 after acquiring an additional 66,400 shares during the period. Finally, Susquehanna International Group LLP acquired a new position in Nexalin Technology in the 3rd quarter valued at about $57,000. 0.65% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

NXL has been the subject of a number of research reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Nexalin Technology in a research report on Monday, December 29th. Wall Street Zen cut Nexalin Technology from a “hold” rating to a “sell” rating in a research report on Saturday, November 22nd. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, Nexalin Technology currently has an average rating of “Hold” and a consensus price target of $5.00.

About Nexalin Technology

Nexalin Technology, Inc is a U.S.-based medical device company specializing in noninvasive neuromodulation therapies for mental health conditions. The company develops and markets the Nexalin® medical device platform, which delivers proprietary alternating current waveforms to targeted areas of the brain through forehead-mounted electrodes. Its technology is designed to modulate neural activity without pharmaceuticals, positioning the company within the growing field of digital therapeutics and neurostimulation.

The Nexalin device has received U.S.